The therapeutic effects of Chinese injection Xuebijing on coagulant factors in dogs with septic shock

Chinese Journal of Emergency Medicine

Volumn 18, Issue 2, 2009, Pages 140-143

  Wu, Cai Jun ^a   Li, Chun Sheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Chinese injection; Coagulation; Promote coagulation factors; Septic shock; Xuebijing

Indexed keywords

EID: 60549110905     PISSN: 16710282     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1671-0282.2009.02.007     Document Type: Article

References (7)

1. Boermeester MA, Leeuwen PAM, Coyle SM, et al. Interleukin-1 receptor blockade in patients with sepsis syndrome: evidence that interleukin-1 contributes to the release of interleukin-6, elastase and phospholipase A2, and to the activation of the complement, coagulation and fibrinolytic systems[J]. Arch Surg, 1995, 130(7):739-748.
2. Gando S, Kameue T, Nazaki S, et al. Cytokines, soluble thrombomodulin and disseminated intravascular coagulation in patients with systemic inflammatory response syndrome[J]. Thromb Res, 1995, 80 (60):519-526.
3. Roumen RMH, Redl H, Schlag G, et al. Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blow trauma[J]. Crit Care Med, 1995,23(3):474-480.
4. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovation therapies in sepsis. American colleges of Chest physician/Society of Critical Care Medicine Consensus Conference[J]. Chest, 1992, 101(6):1644-1655.
5. Colvin T. Management of disseminated intravascular coagulation[J]. Br J Haematol, 1998, 101(Suppl):15-17.
6. Gando S, Nanzaki S, Morimoto Y, et al. Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients[J]. Crit Care Med, 2001, 29(2):262-266.
7. Mammen F. The haematological manifestation of sepsis [J]. Antimicrob Chemother, 1998, 41 (Suppl A):17.